
OLD Category: Oncology
November 1, 2021 / J Immunother Cancer
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism
November 1, 2021 / J Immunother Cancer
Synergy between Toxoplasma gondii type I DeltaGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
November 1, 2021 / Mod Pathol
Recurrent CTNNB1 mutations in craniofacial osteomas
November 1, 2021 / Cancers (Basel)
Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
November 1, 2021 / Pac Symp Biocomput
Mixed Effects Machine Learning Models for Colon Cancer Metastasis Prediction using Spatially Localized Immuno-Oncology Markers
November 1, 2021 / J Immunother Cancerbladder cancer
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
November 1, 2021 / BMJ Open Gastroenterol
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
October 31, 2021 / Cancers (Basel)
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
October 29, 2021 / Neuropathol Appl Neurobiol
TUMOUR-ASSOCIATED CD204+ MICROGLIA/MACROPHAGES ACCUMULATE IN PERIVASCULAR AND PERINECROTIC NICHES AND CORRELATE WITH AN INTERLEUKIN-6 ENRICHED INFLAMMATORY PROFILE IN GLIOBLASTOMA
October 28, 2021 / Front Bioeng Biotechnol